INGN Inogen: Company Value to Revenue

Public company logo of Inogen Inc (INGN)

Inogen, Inc. (INGN) seeks to solidify its global leadership in the portable oxygen equipment segment, leveraging its patent protection. The enterprise value-to-revenue ratio is sourced from GURU.Markets data on this chart, where 182.98 reflects the current level of the metric. While mobile devices for lightweight use provided a competitive advantage, a temporary liquidity shortage resulting from the restructuring of business processes is currently hindering the company's growth dynamics.

Inogen Inc (INGN): EV/Sales Multiple from 11/23/2025 to 11/19/2026

Inogen - analytical breakdowns and key metrics (INGN)

- current price and projected stock value:
- company stock capitalization data:
Fundamental company valuation:INGN - Inogen Medical
Original product of inogen.com

Inogen, Inc. (INGN) leadership in the portable oxygen concentrator niche is currently weakened by pricing pressure from Asian competitors. Under these conditions, the firm's EV/Sales multiple valuation helps isolate the impact of debt load on capitalization. This indicator compares the total enterprise value with actual sales volume, revealing speculative overheating of quotes. Peaks on this chart signal a disconnect between market expectations and actual revenue. Exceeding historical averages indicates a risk of asset value correction.